(Q48676257)

14 February 2018

title

Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease (English)

1 reference

14 February 2018

1 reference

3

Henk W Berendse

1 reference

14 February 2018

Anke A Dijkstra

1

1 reference

14 February 2018

Pieter Voorn

2

1 reference

14 February 2018

Henk J Groenewegen

4

1 reference

14 February 2018

Netherlands Brain Bank

5

1 reference

14 February 2018

Annemieke J M Rozemuller

6

1 reference

14 February 2018

Wilma D J van de Berg

7

1 reference

14 February 2018

language of work or name

English

0 references

publication date

3 July 2014

1 reference

14 February 2018

published in

Movement Disorders

1 reference

14 February 2018

volume

29

1 reference

14 February 2018

issue

10

1 reference

14 February 2018

page(s)

1244-1251

1 reference

14 February 2018

1 reference

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

alpha-Synuclein and neuronal cell death

21 January 2018

1 reference

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

21 January 2018

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model

21 January 2018

1 reference

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

21 January 2018

1 reference

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

21 January 2018

1 reference

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease

21 January 2018

1 reference

Incidental Lewy body disease and preclinical Parkinson disease

21 January 2018

1 reference

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease

21 January 2018

1 reference

Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra

21 January 2018

1 reference

Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

21 January 2018

1 reference

Ageing, neurodegeneration and Parkinson's disease

21 January 2018

1 reference

Design-based stereology in neuroscience

21 January 2018

1 reference

Nigral burden of alpha-synuclein correlates with striatal dopamine deficit

21 January 2018

1 reference

A clinico-pathological study of subtypes in Parkinson's disease

21 January 2018

1 reference

Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?

21 January 2018

1 reference

Neuropathology underlying clinical variability in patients with synucleinopathies

21 January 2018

1 reference

Nigral pathology and parkinsonian signs in elders without Parkinson disease

21 January 2018

1 reference

Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity

21 January 2018

1 reference

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

21 January 2018

1 reference

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

21 January 2018

1 reference

Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra

21 January 2018

1 reference

The progression of pathology in Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25952

1 reference

14 February 2018

1 reference

14 February 2018